BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kao YS, Yu CY, Huang HJ, Tien SM, Wang WY, Yang M, Anderson R, Yeh TM, Lin YS, Wan SW. Combination of Modified NS1 and NS3 as a Novel Vaccine Strategy against Dengue Virus Infection. J Immunol 2019;203:1909-17. [PMID: 31451673 DOI: 10.4049/jimmunol.1900136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Fang E, Liu X, Liu X, Li M, Wang L, Li M, Zhang Z, Li Y, Yu Y. Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice. MedComm 2022;3. [DOI: 10.1002/mco2.117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Shoushtari M, Mafakher L, Rahmati S, Salehi-vaziri M, Arashkia A, Roohvand F, Teimoori-toolabi L, Azadmanesh K. Designing vaccine candidates against dengue virus by in silico studies on structural and nonstructural domains. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101818] [Reference Citation Analysis]
3 Huang H, Yang M, Chen H, Wang S, Chang C, Ho T, Kao Y, Tien S, Lin H, Chang P, Lai Y, Hsiao Y, Liu Y, Chao C, Anderson R, Yeh T, Lin Y, Wan S. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.070] [Reference Citation Analysis]
4 Islam MT, Quispe C, Herrera-Bravo J, Sarkar C, Sharma R, Garg N, Fredes LI, Martorell M, Alshehri MM, Sharifi-Rad J, Daştan SD, Calina D, Alsafi R, Alghamdi S, Batiha GE, Cruz-Martins N. Production, Transmission, Pathogenesis, and Control of Dengue Virus: A Literature-Based Undivided Perspective. Biomed Res Int 2021;2021:4224816. [PMID: 34957305 DOI: 10.1155/2021/4224816] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Manh DH, Weiss LN, Thuong NV, Mizukami S, Dumre SP, Luong QC, Thanh LC, Thang CM, Huu PT, Phuc LH, Nhung CTH, Mai NT, Truong NQ, Ngu VTT, Quoc DK, Ha TTN, Ton T, An TV, Halhouli O, Quynh LN, Kamel MG, Karbwang J, Huong VTQ, Huy NT, Hirayama K. Kinetics of CD4+ T Helper and CD8+ Effector T Cell Responses in Acute Dengue Patients. Front Immunol 2020;11:1980. [PMID: 33072068 DOI: 10.3389/fimmu.2020.01980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chen RE, Diamond MS. Dengue mouse models for evaluating pathogenesis and countermeasures. Curr Opin Virol 2020;43:50-8. [PMID: 32950933 DOI: 10.1016/j.coviro.2020.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
7 Araujo SC, Pereira LR, Alves RPS, Andreata-Santos R, Kanno AI, Ferreira LCS, Gonçalves VM. Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli. Vaccines (Basel) 2020;8:E492. [PMID: 32878023 DOI: 10.3390/vaccines8030492] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Idris F, Ting DHR, Alonso S. An update on dengue vaccine development, challenges, and future perspectives. Expert Opin Drug Discov 2021;16:47-58. [PMID: 32838577 DOI: 10.1080/17460441.2020.1811675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wilken L, Rimmelzwaan GF. Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design? Pathogens 2020;9:E470. [PMID: 32549226 DOI: 10.3390/pathogens9060470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]